BCV Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$201K Buy
+3,700
New +$166K 0.01% 111

Other funds holding ARKG

BCV Asset Management's ARKG Position: Q3 2026 in Review

BCV Asset Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 3,700 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #111 among its holdings.

316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • BCV Asset Management held 3,700 shares of ARK Genomic Revolution ETF worth $201K as of Q3 2026.
  • ARK Genomic Revolution ETF was a new BCV Asset Management position in Q3 2026.
  • ARK Genomic Revolution ETF made up 0.01% of BCV Asset Management's portfolio in Q3 2026, its #111 holding.
  • 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on BCV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.